Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sejong Han

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of abiraterone acetate for treating metastatic castration-resistant prostate cancerChristopher Sejong Han, Rutveej Patel, Isaac Yi Kim
American Journal of Clinical and Experimental Urology|November 7, 2014
Active surveillance in men with low-risk prostate cancer: current and future challengesChristopher Sejong Han, Jaspreet Singh Parihar, Isaac Yi Kim
Thescientificworldjournal|September 13, 2014
Numerical study on tsunami hazard mitigation using a submerged breakwaterTaemin Ha, Jeseon Yoo, Sejong Han, et al.
International Journal of Molecular Sciences|September 23, 2022
Comparative Genomic Analysis of Agarolytic <i>Flavobacterium faecale</i> WV33<sup>T</sup>Jun Ho Lee, Seong-Rae Lee, Sejong Han, et al.
World Journal of Nephrology and Urology|April 19, 2016
Renal Leiomyosarcoma: Case Report and Review of the LiteratureYoung Suk Kwon, Amirali Salmasi, Christopher Sejong Han, et al.
The Journal of Urology|November 27, 2015
Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate CancerJiwoong Yu, Young Suk Kwon, Sinae Kim, et al.
Clinical Genitourinary Cancer|September 6, 2015
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate CancerYoung Suk Kwon, Christopher Sejong Han, Ji Woong Yu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of abiraterone acetate for treating metastatic castration-resistant prostate cancerChristopher Sejong Han, Rutveej Patel, Isaac Yi Kim
American Journal of Clinical and Experimental Urology|November 7, 2014
Active surveillance in men with low-risk prostate cancer: current and future challengesChristopher Sejong Han, Jaspreet Singh Parihar, Isaac Yi Kim
Thescientificworldjournal|September 13, 2014
Numerical study on tsunami hazard mitigation using a submerged breakwaterTaemin Ha, Jeseon Yoo, Sejong Han, et al.
International Journal of Molecular Sciences|September 23, 2022
Comparative Genomic Analysis of Agarolytic <i>Flavobacterium faecale</i> WV33<sup>T</sup>Jun Ho Lee, Seong-Rae Lee, Sejong Han, et al.
World Journal of Nephrology and Urology|April 19, 2016
Renal Leiomyosarcoma: Case Report and Review of the LiteratureYoung Suk Kwon, Amirali Salmasi, Christopher Sejong Han, et al.
The Journal of Urology|November 27, 2015
Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate CancerJiwoong Yu, Young Suk Kwon, Sinae Kim, et al.
Clinical Genitourinary Cancer|September 6, 2015
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate CancerYoung Suk Kwon, Christopher Sejong Han, Ji Woong Yu, et al.
Pageof 1